• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用含有抗靶细胞抗体和抗Fcγ受体抗体的异源交联聚集体产生靶向特异性效应细胞。

Production of target-specific effector cells using hetero-cross-linked aggregates containing anti-target cell and anti-Fc gamma receptor antibodies.

作者信息

Karpovsky B, Titus J A, Stephany D A, Segal D M

出版信息

J Exp Med. 1984 Dec 1;160(6):1686-701. doi: 10.1084/jem.160.6.1686.

DOI:10.1084/jem.160.6.1686
PMID:6239899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2187539/
Abstract

Rabbit anti-2,4-dintrophenyl (DNP) antibodies or their F(ab')2 fragments were chemically cross-linked to the anti-mouse Fc gamma R monoclonal antibody 2.4G2 or to its Fab fragment. P388D1 cells were incubated with heteroaggregates between 2.4G2 and anti-DNP (anti-Fc gamma R X anti-DNP) and washed. The resulting cells lysed 2,4,6-trinitrophenyl chicken erythrocytes (TNP CRBC) in a hapten-specific manner. The lysis was inhibited by free hapten but was resistant to inhibition by immune complexes. Other cells coated with antibody heteroaggregates also mediated lysis of TNP-modified target cells. For example, mouse resident peritoneal exudate cells (PEC) lysed TNP CRBC and bacillus Calmette-Guérin-activated PEC lysed both TNP CRBC and TNP tumor targets. Human neutrophils, when incubated with heteroaggregates containing the anti-human neutrophil Fc gamma R antibody 3G8 and anti-DNP also lysed TNP CRBC and TNP-modified tumor cells. To test whether linkage to Fc gamma R was required for lysis, F(ab')2 fragments from the anti-KdDd monoclonal antibody 34-1-2 were cross-linked to anti-DNP F(ab')2 fragments. P388D1 cells (which express Kd and Dd) were then incubated with these heteroaggregates and washed, and their abilities to form conjugates and lyse TNP CRBC were compared with those of P388D1 cells treated with anti-Fc gamma R X anti-DNP. In both cases, P388D1 cells formed conjugates. However, only the cells treated with anti-Fc gamma R X anti-DNP mediated lysis to a significant extent. We conclude that heteroaggregates containing anti-Fc gamma R and anti-target cell antibodies can be used to create potent effector cells against red cell and tumor targets and that bridging of effectors with target cells directly to Fc gamma R on effector cells is required for lysis.

摘要

兔抗2,4 - 二硝基苯基(DNP)抗体或其F(ab')2片段与抗小鼠FcγR单克隆抗体2.4G2或其Fab片段进行化学交联。将P388D1细胞与2.4G2和抗DNP之间的异聚体(抗FcγR×抗DNP)一起孵育并洗涤。所得细胞以半抗原特异性方式裂解2,4,6 - 三硝基苯基鸡红细胞(TNP CRBC)。这种裂解被游离半抗原抑制,但对免疫复合物的抑制具有抗性。其他包被有抗体异聚体的细胞也介导TNP修饰靶细胞的裂解。例如,小鼠驻留腹膜渗出细胞(PEC)裂解TNP CRBC,卡介苗激活的PEC裂解TNP CRBC和TNP肿瘤靶细胞。人中性粒细胞与含有抗人中性粒细胞FcγR抗体3G8和抗DNP的异聚体一起孵育时,也裂解TNP CRBC和TNP修饰的肿瘤细胞。为了测试裂解是否需要与FcγR连接,将抗KdDd单克隆抗体34 - 1 - 2的F(ab')2片段与抗DNP F(ab')2片段交联。然后将P388D1细胞(表达Kd和Dd)与这些异聚体一起孵育并洗涤,并将它们形成结合物和裂解TNP CRBC的能力与用抗FcγR×抗DNP处理的P388D1细胞进行比较。在两种情况下,P388D1细胞都形成了结合物。然而,只有用抗FcγR×抗DNP处理的细胞在很大程度上介导了裂解。我们得出结论,含有抗FcγR和抗靶细胞抗体的异聚体可用于产生针对红细胞和肿瘤靶标的强效效应细胞,并且效应细胞与靶细胞直接桥接至效应细胞上的FcγR对于裂解是必需的。

相似文献

1
Production of target-specific effector cells using hetero-cross-linked aggregates containing anti-target cell and anti-Fc gamma receptor antibodies.使用含有抗靶细胞抗体和抗Fcγ受体抗体的异源交联聚集体产生靶向特异性效应细胞。
J Exp Med. 1984 Dec 1;160(6):1686-701. doi: 10.1084/jem.160.6.1686.
2
Human K/natural killer cells targeted with hetero-cross-linked antibodies specifically lyse tumor cells in vitro and prevent tumor growth in vivo.用异源交联抗体靶向的人杀伤细胞/自然杀伤细胞在体外能特异性裂解肿瘤细胞,并在体内抑制肿瘤生长。
J Immunol. 1987 Nov 1;139(9):3153-8.
3
Characterization of a new monoclonal anti-Fc gamma RII antibody, AT10, and its incorporation into a bispecific F(ab')2 derivative for recruitment of cytotoxic effectors.一种新型抗FcγRII单克隆抗体AT10的特性及其掺入双特异性F(ab')2衍生物以募集细胞毒性效应物的研究
Mol Immunol. 1991 Nov;28(11):1243-54. doi: 10.1016/0161-5890(91)90011-8.
4
Production and characterization of monoclonal antibodies to Fc gamma 2a-binding protein isolated from the detergent lysate of a murine macrophagelike cell line, P388D1.从鼠巨噬细胞样细胞系P388D1的去污剂裂解物中分离出的Fcγ2a结合蛋白的单克隆抗体的制备及特性鉴定
J Leukoc Biol. 1989 Apr;45(4):311-21. doi: 10.1002/jlb.45.4.311.
5
Comparative efficiencies of bispecific F(ab'gamma)2 and chimeric mouse/human IgG antibodies in recruiting cellular effectors for cytotoxicity via Fc gamma receptors.双特异性F(ab'γ)2和嵌合型小鼠/人IgG抗体通过Fcγ受体募集细胞效应器以发挥细胞毒性作用的比较效率
Cancer Immunol Immunother. 1992;34(6):361-9. doi: 10.1007/BF01741745.
6
Comparison of the ability of red cells sensitized with a bispecific anti-D x anti-Fc gamma RIII Fab fragment to activate human K cells and peritoneal macrophages through Fc gamma RIII.用双特异性抗-D×抗-FcγRIII Fab片段致敏的红细胞通过FcγRIII激活人K细胞和腹腔巨噬细胞的能力比较。
Immunol Lett. 1994 Sep;42(1-2):91-5. doi: 10.1016/0165-2478(94)90041-8.
7
Potentiation of tumor lysis by a bispecific antibody that binds to CA19-9 antigen and the Fc gamma receptor expressed by human large granular lymphocytes.一种双特异性抗体对肿瘤溶解的增强作用,该抗体可结合CA19-9抗原和人类大颗粒淋巴细胞表达的Fcγ受体。
Cancer Res. 1990 Nov 15;50(22):7123-8.
8
Heterogeneity of human lymphocyte Fc receptors: studies using heat-aggregated and antigen-complexed IgG from human, rabbit, guinea pig, horse and goat.人淋巴细胞Fc受体的异质性:使用来自人、兔、豚鼠、马和山羊的热聚集IgG及抗原复合IgG的研究
Comp Immunol Microbiol Infect Dis. 1982;5(4):483-99. doi: 10.1016/0147-9571(82)90074-1.
9
Preparation and performance of bispecific F(ab' gamma)2 antibody containing thioether-linked Fab' gamma fragments.含硫醚连接Fab'γ片段的双特异性F(ab'γ)2抗体的制备与性能
J Immunol. 1987 Oct 1;139(7):2367-75.
10
Distinct functions of surface receptors in the induction of neutrophil-mediated cytotoxicity.表面受体在诱导中性粒细胞介导的细胞毒性中的不同功能。
Ann Immunol (Paris). 1981 Jul-Aug;132D(1):3-14.

引用本文的文献

1
Clinical Progresses and Challenges of Bispecific Antibodies for the Treatment of Solid Tumors.双特异性抗体治疗实体瘤的临床进展与挑战。
Mol Diagn Ther. 2024 Nov;28(6):669-702. doi: 10.1007/s40291-024-00734-w. Epub 2024 Aug 22.
2
Revolutionizing cancer treatment: the power of bi- and tri-specific T-cell engagers in oncolytic virotherapy.革新癌症治疗:双特异性和三特异性T细胞衔接器在溶瘤病毒疗法中的力量
Front Immunol. 2024 Feb 22;15:1343378. doi: 10.3389/fimmu.2024.1343378. eCollection 2024.
3
Chemical and Enzymatic Methods for Post-Translational Protein-Protein Conjugation.化学和酶法用于翻译后蛋白质-蛋白质偶联。
J Am Chem Soc. 2022 Aug 17;144(32):14404-14419. doi: 10.1021/jacs.2c00129. Epub 2022 Jul 31.
4
Taking up Cancer Immunotherapy Challenges: Bispecific Antibodies, the Path Forward?迎接癌症免疫治疗挑战:双特异性抗体,前行之路?
Antibodies (Basel). 2015 Dec 26;5(1):1. doi: 10.3390/antib5010001.
5
Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer Cells.双特异性T细胞重定向与嵌合抗原受体(CAR)-T细胞作为杀伤癌细胞的方法。
Antibodies (Basel). 2019 Jul 3;8(3):41. doi: 10.3390/antib8030041.
6
Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics.双特异性和三特异性抗体——实体瘤治疗的下一个大事件。
Mol Med. 2018 Sep 24;24(1):50. doi: 10.1186/s10020-018-0051-4.
7
Engineering multi-specific antibodies against HIV-1.工程多特异性抗体对抗 HIV-1。
Retrovirology. 2018 Aug 29;15(1):60. doi: 10.1186/s12977-018-0439-9.
8
Molecular checkpoints controlling natural killer cell activation and their modulation for cancer immunotherapy.控制自然杀伤细胞激活的分子检查点及其在癌症免疫治疗中的调节作用。
Exp Mol Med. 2017 Mar 31;49(3):e311. doi: 10.1038/emm.2017.42.
9
Purified anti-CD3 × anti-HER2 bispecific antibody potentiates cytokine-induced killer cells of poor spontaneous cytotoxicity against breast cancer cells.纯化的抗 CD3×抗 HER2 双特异性抗体增强了对乳腺癌细胞低自发细胞毒性的细胞因子诱导的杀伤细胞。
Cell Biosci. 2014 Nov 25;4(1):70. doi: 10.1186/2045-3701-4-70. eCollection 2014.
10
Homogeneous bispecifics by disulfide bridging.通过二硫键桥连的均相双特异性分子。
Bioconjug Chem. 2014 Aug 20;25(8):1395-401. doi: 10.1021/bc5002467. Epub 2014 Aug 1.

本文引用的文献

1
Antibody-dependent cell-mediated cytolysis (ADCC) with antibody-coated effectors: new methods for enhancing antibody binding and cytolysis.抗体包被效应细胞介导的抗体依赖性细胞毒性作用(ADCC):增强抗体结合和细胞毒性作用的新方法。
J Immunol. 1980 Aug;125(2):926-33.
2
Monoclonal antibodies to mouse major histocompatibility complex antigens.针对小鼠主要组织相容性复合体抗原的单克隆抗体。
Transplantation. 1982 Sep;34(3):113-20. doi: 10.1097/00007890-198209000-00001.
3
Directed effector cells selectively lyse human tumour cells.定向效应细胞可选择性地裂解人类肿瘤细胞。
Nature. 1982 May 20;297(5863):234-6. doi: 10.1038/297234a0.
4
Antibody-dependent, cell-mediated cytolysis (ADCC) with antibody-coated effectors: rat and human effectors versus tumor targets.抗体包被效应细胞介导的抗体依赖性细胞溶解作用(ADCC):大鼠和人类效应细胞与肿瘤靶标的研究
J Immunol. 1981 Jun;126(6):2457-60.
5
Role of activated macrophages in antibody-dependent lysis of tumor cells.活化巨噬细胞在肿瘤细胞抗体依赖性裂解中的作用。
J Exp Med. 1980 Jul 1;152(1):183-97. doi: 10.1084/jem.152.1.183.
6
The FcR-mediated endocytosis of model immune complexes by cells from the P388D1 mouse macrophage line. II. The role of ligand-induced self-aggregation in promoting internalization.P388D1小鼠巨噬细胞系细胞通过FcR介导的模型免疫复合物的内吞作用。II. 配体诱导的自我聚集在促进内化中的作用。
J Immunol. 1983 Jan;130(1):138-44.
7
Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation.中性粒细胞氧化产物形成的流式细胞术研究:对膜刺激的分级反应。
J Immunol. 1983 Apr;130(4):1910-7.
8
Human neutrophil Fc gamma receptor distribution and structure.人类中性粒细胞Fcγ受体的分布与结构。
Proc Natl Acad Sci U S A. 1982 May;79(10):3275-9. doi: 10.1073/pnas.79.10.3275.
9
The cytotoxic effector cells in preparations of adherent mononuclear cells from human peripheral blood.来自人外周血的贴壁单核细胞制剂中的细胞毒性效应细胞。
J Immunol. 1984 Mar;132(3):1255-60.
10
Monoclonal antibody-directed effector cells selectively lyse human melanoma cells in vitro and in vivo.单克隆抗体导向的效应细胞在体外和体内均可选择性地裂解人黑色素瘤细胞。
Proc Natl Acad Sci U S A. 1983 Sep;80(17):5407-11. doi: 10.1073/pnas.80.17.5407.